TR199801839T2 - - Google Patents

Info

Publication number
TR199801839T2
TR199801839T2 TR1998/01839T TR9801839T TR199801839T2 TR 199801839 T2 TR199801839 T2 TR 199801839T2 TR 1998/01839 T TR1998/01839 T TR 1998/01839T TR 9801839 T TR9801839 T TR 9801839T TR 199801839 T2 TR199801839 T2 TR 199801839T2
Authority
TR
Turkey
Prior art keywords
group
alkyl
alkoxy
hydrogen
halogen atom
Prior art date
Application number
TR1998/01839T
Other languages
Turkish (tr)
Inventor
Sevrin Mireille
Marabout Benoit
George Pascal
Merly Jean-Pierre
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of TR199801839T2 publication Critical patent/TR199801839T2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Asagidaki genel formüle (I) karsilik gelen bilesikler olup burada; R1, R2 ve R3'den her biri bir hidrojen veya halojen atomunu veya bir hidroksil, alkil veya alkoksi grubunu simgelemekte, R4 bir hidrojen veya halojen atomunu veya bir alkil, 2-metoksietoksi, alkoksi, sikloalkilmetoksi veya fenilmetoksi grubunu simgelemekte, veya alternatif olarak R3 ve R4 birlikte bir metilendioksi grubunu olusturmakta, Z oksijen veya iki hidrojen atomunu simgelemekte ve R;Z oksijeni veya alternatif olarak istege bagli bir sekilde bir veya daha fazla halojen atomuyla veya alkil, alkoksi veya amino gruplariyla yer degistirilmis bir fenil grubunu simgelediginde bir etoksi grubunu simgelemektedir. Tedavi maksatli uygulamadir.Compounds corresponding to the general formula (I) below are; R1, R2 and R3 each represents a hydrogen or halogen atom or a hydroxyl, alkyl or alkoxy group, R4 represents a hydrogen or halogen atom or an alkyl, 2-methoxyethoxy, alkoxy, cycloalkylmethoxy or phenylmethoxy group, or alternatively R3 and R4 together form a methylenedioxy group, Z represents oxygen or two hydrogen atoms, and R represents an oxygen group or an ethoxy group optionally substituted by one or more halogen atoms or alkyl, alkoxy or amino groups optionally. . The treatment is purposive application.

TR1998/01839T 1996-04-12 1997-04-10 TR199801839T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9604565A FR2747386B1 (en) 1996-04-12 1996-04-12 DERIVATIVES OF 3 - [(1,2,3,4-TETRAHYDROISOQUINOLEIN-2-YL) METHYL] -8-AZABICYCLO [3.2.1] OCTANE, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Publications (1)

Publication Number Publication Date
TR199801839T2 true TR199801839T2 (en) 1998-12-21

Family

ID=9491132

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01839T TR199801839T2 (en) 1996-04-12 1997-04-10

Country Status (22)

Country Link
EP (1) EP0892800A1 (en)
JP (1) JP2000512620A (en)
KR (1) KR20000005392A (en)
CN (1) CN1216046A (en)
AR (1) AR008587A1 (en)
AU (1) AU2640997A (en)
BG (1) BG102779A (en)
BR (1) BR9708654A (en)
CA (1) CA2251335A1 (en)
CO (1) CO4900067A1 (en)
CZ (1) CZ326898A3 (en)
EE (1) EE9800396A (en)
FR (1) FR2747386B1 (en)
IL (1) IL126473A0 (en)
NO (1) NO984736L (en)
NZ (1) NZ332257A (en)
PL (1) PL329243A1 (en)
SK (1) SK141598A3 (en)
TR (1) TR199801839T2 (en)
TW (1) TW407158B (en)
WO (1) WO1997038998A1 (en)
ZA (1) ZA973124B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2303851A1 (en) * 2008-06-27 2011-04-06 H. Lundbeck A/S Novel phenolic and catecholic amines and prodrugs thereof
EP3495363B1 (en) 2016-07-28 2023-08-23 Shionogi & Co., Ltd Nitrogen-containing condensed ring compounds having dopamine d3 receptor antagonistic effect
US11578084B2 (en) 2018-01-26 2023-02-14 Shionogi & Co., Ltd. Condensed ring compounds having dopamine D3 receptor antagonistic effect

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
EP0306375A1 (en) * 1987-08-07 1989-03-08 Synthelabo 2-[(4-Piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline derivatives, their preparation and their use in therapy
IL89156A (en) * 1988-07-12 1993-05-13 Synthelabo Derivatives of 2-((4-piperidinyl) methyl)- 1,2,3,4- tetrahydroisoquinoline, their preparation and their application in therapeutics
FR2661178B1 (en) * 1990-04-24 1993-03-12 Synthelabo DERIVATIVES OF [(TETRAHYDRO-1,2,3,4 ISOQUINOLEINYL-2) METHYL] -4 PIPERIDINECARBOXYLATES-1 OF ALKYL, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.

Also Published As

Publication number Publication date
EE9800396A (en) 1999-06-15
NZ332257A (en) 1999-03-29
CN1216046A (en) 1999-05-05
AU2640997A (en) 1997-11-07
BG102779A (en) 1999-09-30
NO984736L (en) 1998-11-23
KR20000005392A (en) 2000-01-25
JP2000512620A (en) 2000-09-26
BR9708654A (en) 1999-08-03
CZ326898A3 (en) 1999-01-13
FR2747386A1 (en) 1997-10-17
CA2251335A1 (en) 1997-10-23
NO984736D0 (en) 1998-10-09
EP0892800A1 (en) 1999-01-27
IL126473A0 (en) 1999-08-17
SK141598A3 (en) 1999-03-12
FR2747386B1 (en) 1998-05-15
AR008587A1 (en) 2000-02-09
CO4900067A1 (en) 2000-03-27
WO1997038998A1 (en) 1997-10-23
ZA973124B (en) 1997-11-05
PL329243A1 (en) 1999-03-15
TW407158B (en) 2000-10-01

Similar Documents

Publication Publication Date Title
FI970246A7 (en) Dihydrobenzofurans
ES8306141A1 (en) Carbostyril derivatives and pharmaceutical composition containing the same
TR200800474T2 (en) Process for the preparation of intermediates of fluorfenicol.
HUP0001192A2 (en) The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity
TR199802374T2 (en) Method for obtaining polyalkenamines.
CO5050332A1 (en) FUNGICIDE COMPOSITIONS THAT INCLUDE 2-METOXIBENZOPHENONES
TR200400857T4 (en) Derivatives and analogs of new galantamine
DK0918776T3 (en) Total synthesis of antitumor acylfulvenes
EA200100310A1 (en) OXYGEN CONTAINING HETEROCYCLIC COMPOUNDS
LU92263I2 (en) Imépitoin and its pharmaceutically acceptable derivatives (PEXION)
AR247744A1 (en) Organosilane compounds
EA200300044A1 (en) NEW SUBSTITUTED PHTHALIDES, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
ES8800122A1 (en) Indene and naphthalene derivatives.
SE8503415D0 (en) NOVEL ISOINDOLINYL-ALKYL-PIPERAZINES
MX9701949A (en) Bis-(2-haloethyl)aminophenyl substituted distamycin derivatives as antitumor and antiviral agents.
SE8500107D0 (en) NEW 8ALFA-ACYLAMINOERGOLINE
ATE92470T1 (en) CARBOXYALKYL ETHER OF 2-AMINO-7-HYDROXYTETRALINE.
TR200000942T2 (en) 8-Azabisayklo (3.2.1) octane-3-methanamine derivatives, their preparation and therapeutic applications.
TR199801839T2 (en)
TR199902873T2 (en) Myozun mod�lasyonu i�in 17�-allyloxy(thio)alkyl-androstane ter�revelier.
TR200200347T2 (en) 1,4-Substituted 4,4-diaryl cyclohexanes.
ATE200482T1 (en) N-SUBSTITUTED AZABICYCLOHEPTAN DERIVATIVES AS NEUROLEPTICS, ETC.
MA24197A1 (en) NEW FUNGARRESTINES
DK0788491T3 (en) 6-Polyfluoroalkoxy and 6-polyfluoroalkyl-2-aminobenzothiazole derivatives
TR199801683A2 (en) New versions.